Guidance for Collegium Pharma (COLL)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2025 | N/A | N/A | $775.00M – 785.00M | $751.60M | = Maintained | Details |
| 2025 | N/A | N/A | $745.00M – 760.00M | $745.80M | = Maintained | Details |
| 2024 | N/A | N/A | $585.00M – 595.00M | $605.80M | = Maintained | Details |
| 2024 | N/A | N/A | $580.00M – 595.00M | $581.70M | = Maintained | Details |
| 2024 | N/A | N/A | $580.00M – 595.00M | $582.90M | = Maintained | Details |
| 2023 | N/A | N/A | $565.00M – 580.00M | $569.70M | = Maintained | Details |
| 2022 | N/A | N/A | $450.00M – 465.00M | N/A | = Maintained | Details |
| Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
